USD 18.6 billion
Report ID:
SQMIG35I2115 |
Region:
Global |
Published Date: March, 2025
Pages:
219
|Tables:
62
|Figures:
78
Global Menopause Market size was valued at USD 18.6 billion in 2023 and is poised to grow from USD 19.72 billion in 2024 to USD 31.42 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).
Menopause is a natural biological process that marks the end of a woman's reproductive years. It usually occurs between the ages of 45 and 55, and is characterized by the cessation of menstrual periods. During menopause, women may experience a range of symptoms, including hot flashes, night sweats, mood changes, and vaginal dryness. There is a growing market for nutritional supplements and other products that are designed to help women manage the symptoms of menopause. These products include herbal supplements, vitamins, minerals, and other dietary supplements, as well as over-the-counter and prescription medications. The global menopause market is expected to grow significantly in the coming years, driven by factors such as increasing awareness about the health benefits of nutritional supplements, growing demand for natural and organic products, and rising incidence of menopause-related health issues. Also, the menopause market is driven by a number of factors, including the aging of the global population, rising awareness of menopause-related health issues, and growing demand for natural and organic products. In addition, women are becoming more active and engaged in managing their health and wellness during menopause, which is driving the development of new products and services.
The increasing prevalence of vasomotor and menopausal symptoms, such as night sweats and hot flashes, among women during the menopausal transition is anticipated to drive market growth. Menopausal symptoms, including mood swings, difficulty concentrating, and depression, are also associated with this phase. A study published in the International Journal of Applied & Basic Medical Research revealed that 36.7% of women reported hot flashes among the 87.7% experiencing menopausal symptoms. Anxiety was the most reported symptom at 80%, followed by sleep issues at 61.2%. While hormone replacement therapy remains the primary treatment for menopausal symptoms, particularly vasomotor symptoms, its use is associated with potential adverse effects such as vaginal bleeding, fractures, dementia, urinary incontinence, breast cancer, heart attack, blood clots, stroke, and colorectal cancer. Consequently, patients are increasingly seeking safer alternatives like plant-based products and dietary supplements. The pandemic negatively impacted the mental health of women, leading to hormonal imbalances and an exacerbation of vasomotor symptoms. Despite the initial adverse effects on the market, sales of over-the-counter pharmaceutical products and dietary supplements witnessed a surge in the third and fourth quarters of 2020. A study by the Council for Responsible Nutrition (CRN) in August 2020 reported an increase in dietary supplement usage during the pandemic. The growing demand for dietary supplements is expected to persist due to a shift in consumer preference toward nature-based alternatives over synthetic pharmaceutical products.
US Menopause Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 18.6 billion
Largest Segment
Dietary Supplements
Fastest Growth
Dietary Supplements
Growth Rate
6.0% CAGR
To get more reports on the above market click here to Buy The Report
Global Menopause Market is segmented by Treatment, Product Type, Indication, Distribution Challenge, Age Group and region. Based on Treatment, the market is segmented into Dietary Supplements and OTC Pharma Products. Based on Product Type, the market is segmented into Gel, Injection, Oral Dosage, Patch, Pill, Powder, Skin Cream, Skin Spray (Transdermal), Vaginal Cream and Vaginal Ring. Based on Indication, the market is segmented into Dry Eyes, Dry Skin, Hot Flashes, Mood Swings, Mild depression & Irritability, Night Sweats and Cold Flashes., Osteoporosis, Trouble Sleeping, Urinary Urgency and Vaginal Dryness. Based on Distribution Challenge, the market is segmented into Hospital Pharmacies, Online Stores and Retail Pharmacies. Based on Age Group, the market is segmented into Premature Menopause, Early Menopause, Average Menopause and Late Menopause. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
During the projected period, the dietary supplements segment dominated the market for Menopause in 2022. This dominance is attributed to factors such as, advantages of nutritional supplements and dangers of hormone replacement therapy. According to a study that was written up in the Journal for Nutraceuticals, supplements like primrose oil, black cohosh, soy isoflavones, and chasteberry helped to relieve hot flashes with sweating, depression, and sleep problems.
The OTC pharmaceutical products market is anticipated to grow profitably during the forecast period. This can be attributed to a change in pharmaceutical companies' development of over-the-counter (OTC) medications to treat menopausal symptoms. For instance, Theramex purchased the product license for Femarelle, an over-the-counter medication used to treat menopausal symptoms, in November 2021. By 2022, the product—which was initially developed by Se-cure Pharmaceuticals Ltd.—will be accessible in a number of nations.
To get detailed analysis on other segments, Request For Free Sample Report
The North America region is anticipated to dominate the market for Menopause market. This dominance is owing to the large population of women undergoing menopause in North America, which increases demand for menopause-related goods and services. Also, compared to other markets, the North American market may have healthcare systems that are more advanced and greater access to these goods and services.
However, due to the rising demand for menopause-related goods and services as well as the increased knowledge of symptoms associated to the menopause, emerging regions like Asia-Pacific and Latin America may present considerable growth potential. Moreover, factors including rising disposable incomes, bettering healthcare infrastructure, and expanding healthcare spending may support the expansion of the menopausal market in these areas.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Request Free Customization of this report to help us to meet your business objectives.
With a wide range of businesses joining the market and creating new products and services to meet the demands of women going through menopause, the menopause market is getting more and more competitive. As the industry expands, competition is likely to heat up, forcing businesses to stand out via innovation, efficacy, and safety in order to gain market share.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global menopause market analysis, due to growing aging population, rising awareness, lifestyle factors, and technological advancements are driving the market growth. As the market continues to grow, companies will need to focus on innovation and partnerships to remain competitive.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 18.6 billion |
Market size value in 2032 | USD 31.42 billion |
Growth Rate | 6.0% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Menopause Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Menopause Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Menopause Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Menopause Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Menopause Market size was valued at USD 17.8 Billion in 2023 and is poised to grow from USD 18.75 Billion in 2024 to USD 28.41 Billion by 2032, growing at a CAGR of 5.33% during the forecast period (2025-2032).
With a wide range of businesses joining the market and creating new products and services to meet the demands of women going through menopause, the menopause market is getting more and more competitive. As the industry expands, competition is likely to heat up, forcing businesses to stand out via innovation, efficacy, and safety in order to gain market share. 'Pfizer Inc.', 'Novo Nordisk A/S', 'Allergan plc', 'TherapeuticsMD Inc.', 'Mylan N.V.', 'Teva Pharmaceutical Industries Ltd.', 'Bayer AG', 'Merck & Co. Inc.', 'Johnson & Johnson', 'GlaxoSmithKline plc', 'Eli Lilly and Company', 'Amgen Inc.', 'AbbVie Inc.', 'Pfizer Inc.', 'Novartis International AG', 'Procter & Gamble Co.', 'Roche Holding AG', 'Sanofi SA', 'Serenity Pharmaceuticals LLC', 'Mithra Pharmaceuticals SA', 'In May 2023, Astellas Pharma Inc. obtained approval from the FDA for VEOZAH, a groundbreaking nonhormonal neurokinin 3 (NK3) receptor antagonist. This marks the first-of-its-kind approval for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. ', 'In March 2023, Amyris, Inc. acquired MenoLabs, LLC, a company specializing in menopause treatment and research in this field. This strategic acquisition is poised to facilitate the expansion of Amyris, Inc.'s product portfolio in the realm of menopause treatments. ', 'In March 2022, Aptorum Group Limited, announced the highly anticipated commercial introduction of NativusWell®. This new dietary supplement is designed to support women's health during the various stages of menopause and is specifically targeted for the Chinese market. '
There are several factors driving the menopause market such as, aging population, rising awareness, lifestyle factors, and technological advancements. Also, Changing attitudes and Healthcare access and affordability are some of the other factors driving the market. As the global population ages, more women will enter menopause, leading to a larger market for menopause-related products and services. This demographic trend is expected to continue for the foreseeable future, as life expectancies increase and birth rates decline in many regions. For instance, The North American Menopause Association estimates that 2 million women in the United States experience menopause every year, or roughly 6,000 women every day. According to UN statistics, there will be 985 million women in 2020 who are 50 years of age or older. By 2050, this figure is anticipated to reach 1.65 billion. The market for menopause products has been significantly boosted by growing public knowledge of menopause and its symptoms. The changes that take place during menopause and the health hazards linked to it are becoming well known to women. The demand for goods and services that can assist manage menopause symptoms, like hormone therapy, herbal supplements, and lifestyle changes, has surged as a result of this raised awareness. Lifestyle factors, such as poor diet and lack of exercise, can exacerbate menopause symptoms and increase the demand for products and services that address these issues. Women are increasingly recognizing the importance of a healthy lifestyle during menopause, which has led to a growing market for products and services that promote wellness during this phase of life.
Owing to concerns about the potential hazards of hormone-based treatments, many women are searching for non-hormonal therapy to treat the symptoms of menopause. As a result, there is an increasing need for non-hormonal treatments such herbal medicines, CBT, and mindfulness-based treatments.
The North America region is anticipated to dominate the market for Menopause market. This dominance is owing to the large population of women undergoing menopause in North America, which increases demand for menopause-related goods and services. Also, compared to other markets, the North American market may have healthcare systems that are more advanced and greater access to these goods and services.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35I2115
[email protected]
USA +1 351-333-4748